Showing results (181-190 of 260) with videos related to
Sort By:
Pageof 26
Journal of the American Academy of Dermatology|February 21, 2012
Sensitive and specific assays for routine serological diagnosis of epidermolysis bullosa acquisitaLars Komorowski, Ralf Müller, Artem Vorobyev, et al.Journal of Autoimmunity|September 18, 2012
Recombinant IL-6 treatment protects mice from organ specific autoimmune disease by IL-6 classical signalling-dependent IL-1ra inductionUnni Krishna S R L Samavedam, Kathrin Kalies, Jürgen Scheller, et al.Nature Communications|September 13, 2024
Unbiased screening identifies regulators of cell-cell adhesion and treatment options in pemphigusHenriette Franz, Maitreyi Rathod, Aude Zimmermann, et al.Life (Basel, Switzerland)|February 26, 2025
Localization of Lesions in Autoimmune Blistering Diseases Is Independent of Site-Specific Target Antigen ExpressionTina Rastegar Lari, Louis Macias, Lara Robrahn, et al.Health Technology Assessment (Winchester, England)|April 14, 2017
A randomised controlled trial to compare the safety, effectiveness and cost-effectiveness of doxycycline (200 mg/day) with that of oral prednisolone (0.5 mg/kg/day) for initial treatment of bullous pemphigoid: the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) trialJoanne R Chalmers, Fenella Wojnarowska, Gudula Kirtschig, et al.The Journal of Investigative Dermatology|November 18, 2021
Multiple Modes of Action Mediate the Therapeutic Effect of Intravenous IgG in Experimental Epidermolysis Bullosa AcquisitaElena Pipi, Anika Kasprick, Hiroaki Iwata, et al.Lancet (London, England)|March 11, 2017
Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trialHywel C Williams, Fenella Wojnarowska, Gudula Kirtschig, et al.The Journal of Investigative Dermatology|August 20, 2010
Generation of antibodies of distinct subclasses and specificity is linked to H2s in an active mouse model of epidermolysis bullosa acquisitaRalf J Ludwig, Andreas Recke, Katja Bieber, et al.Frontiers in Immunology|March 31, 2018
Tissue Destruction in Bullous Pemphigoid Can Be Complement Independent and May Be Mitigated by C5aR2Christian M Karsten, Tina Beckmann, Maike M Holtsche, et al.JAMA Dermatology|March 30, 2022
Clinical and Serological Characterization of Orf-Induced Immunobullous DiseaseKaan Yilmaz, Stephanie Goletz, Henri H Pas, et al.Pageof 26